{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:03:40Z","timestamp":1791515020766,"version":"4.3.4"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K12746"],"award-info":[{"award-number":["24K12746"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24KJ1842"],"award-info":[{"award-number":["24KJ1842"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ajo.2025.11.039","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:57:34Z","timestamp":1764172654000},"page":"7-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Subretinal Fluid Duration and Clinical Outcomes in Central Serous Chorioretinopathy: An Analysis of Time-to-Photodynamic Therapy"],"prefix":"10.1016","volume":"283","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5771-6718","authenticated-orcid":false,"given":"Ryoh","family":"Funatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohisa","family":"Mihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoki","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Imatsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takato","family":"Sakono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2208-2118","authenticated-orcid":false,"given":"Hideki","family":"Shiihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozo","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiji","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ajo.2025.11.039_bib0001","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1136\/bjophthalmol-2021-319403","article-title":"Incidence of central serous chorioretinopathy (2011-2018): a nationwide population-based cohort study of Japan","volume":"106","author":"Kido","year":"2022","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.039_bib0002","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ophtha.2007.02.032","article-title":"The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002","volume":"115","author":"Kitzmann","year":"2008","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.039_bib0003","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0161-6420(96)30386-2","article-title":"Central serous chorioretinopathy in younger and older adults","volume":"103","author":"Spaide","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2025.11.039_bib0004","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ajo.2023.04.016","article-title":"A photodynamic therapy index for Central serous chorioretinopathy to predict visual prognosis using pretreatment factors","volume":"253","author":"Funatsu","year":"2023","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.039_bib0005","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2018.12.048","article-title":"Long-term visual outcomes and causes of vision loss in chronic Central serous chorioretinopathy","volume":"126","author":"Mrejen","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2025.11.039_bib0006","doi-asserted-by":"crossref","first-page":"101236","DOI":"10.1016\/j.preteyeres.2024.101236","article-title":"Central serous chorioretinopathy: an evidence-based treatment guideline","volume":"101","author":"Feenstra","year":"2024","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.039_bib0007","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ophtha.2013.09.024","article-title":"Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial","volume":"121","author":"Bae","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2025.11.039_bib0008","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajo.2021.06.020","article-title":"Half-dose photodynamic therapy versus eplerenone in chronic Central serous chorioretinopathy (SPECTRA): a randomized controlled trial","volume":"233","author":"van Rijssen","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.039_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100152","article-title":"Effectiveness of reduced-fluence photodynamic therapy for chronic Central serous chorioretinopathy: a propensity score analysis","volume":"2","author":"Aisu","year":"2022","journal-title":"Ophthalmol Sci"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.039_bib0010","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ophtha.2018.04.021","article-title":"Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic Central serous chorioretinopathy: the PLACE trial","volume":"125","author":"van Dijk","year":"2018","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.039_bib0011","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/00006982-200212000-00002","article-title":"Duration of skin photosensitivity and incidence of photosensitivity reactions after administration of verteporfin","volume":"22","author":"Houle","year":"2002","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.039_bib0012","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ajo.2010.03.015","article-title":"Macular thickness interoperator and intraoperator reproducibility in healthy eyes using 7 optical coherence tomography instruments","volume":"150","author":"Pierro","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"3-4","key":"10.1016\/j.ajo.2025.11.039_bib0013","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000380832","article-title":"Repeatability of retinal macular thickness measurements in healthy subjects and diabetic patients with clinically significant macular edema: evaluation of the follow-up system of Spectralis optical coherence tomography","volume":"233","author":"Fiore","year":"2015","journal-title":"Ophthalmologica"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.039_bib0014","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00417-024-06698-1","article-title":"Predictive risk scores for visual prognosis after photodynamic therapy for central serous chorioretinopathy","volume":"263","author":"Funatsu","year":"2025","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.039_bib0015","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ajo.2023.05.022","article-title":"Characteristics related to visual acuity loss after successful photodynamic therapy for eyes with Central serous chorioretinopathy","volume":"256","author":"Funatsu","year":"2023","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2025.11.039_bib0016","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.oret.2020.07.026","article-title":"Central Serous Chorioretinopathy International Group. Multimodal imaging-based Central serous chorioretinopathy classification","volume":"4","author":"Chhablani","year":"2020","journal-title":"Ophthalmol Retina"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.039_bib0017","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/IAE.0000000000002580","article-title":"Fundus autofluorescence patterns in Central serous chorioretinopathy","volume":"40","author":"Han","year":"2020","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.039_bib0018","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ophtha.2005.01.003","article-title":"Fundus autofluorescence and central serous chorioretinopathy","volume":"112","author":"Spaide","year":"2005","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.039_bib0019","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ajo.2009.01.018","article-title":"Outer nuclear layer thickness at the fovea determines visual outcomes in resolved central serous chorioretinopathy","volume":"148","author":"Matsumoto","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.039_bib0020","article-title":"Changes in the foveal outer nuclear layer of central serous chorioretinopathy patients over the disease course and their response to photodynamic therapy","volume":"8","author":"Deng","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.039_bib0021","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/s41433-020-0996-8","article-title":"Glaucoma-related central visual field deterioration after vitrectomy for epiretinal membrane: topographic characteristics and risk factors","volume":"35","author":"Tsuchiya","year":"2021","journal-title":"EYE"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.039_bib0022","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ajo.2009.08.026","article-title":"Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial","volume":"149","author":"Reibaldi","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.039_bib0023","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/IAE.0000000000002445","article-title":"Elongated photoreceptor outer segment length and prognosis of chronic Central serous chorioretinopathy","volume":"40","author":"Asano","year":"2020","journal-title":"Retina"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425006385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425006385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:15:40Z","timestamp":1781788540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939425006385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":23,"alternative-id":["S0002939425006385"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2025.11.039","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subretinal Fluid Duration and Clinical Outcomes in Central Serous Chorioretinopathy: An Analysis of Time-to-Photodynamic Therapy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2025.11.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}